Revenue: The sum of all revenue fields included for a company's operating activities.
Dianthus Therapeutics, Inc. (DNTH) had Revenue of $6.24M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$6.24M |
$-84.97M |
|
-- |
|
$6.24M |
|
$108.10M |
|
$-101.86M |
|
$16.89M |
|
$-84.97M |
|
$-85.12M |
|
$-84.97M |
|
$-84.97M |
|
$-84.97M |
|
$-85.12M |
|
$-101.86M |
|
$-107.47M |
|
33.31M |
|
33.31M |
|
$-2.55 |
|
$-2.55 |
|
| Balance Sheet Financials | |
$280.90M |
|
$0.19M |
|
$93.10M |
|
$374.01M |
|
$18.45M |
|
-- |
|
$3.08M |
|
$21.53M |
|
$352.48M |
|
$352.48M |
|
$352.48M |
|
31.11M |
|
| Cash Flow Statement Financials | |
$-78.18M |
|
$-286.81M |
|
$255.62M |
|
$132.39M |
|
$23.02M |
|
$-109.37M |
|
$12.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1633.74% |
|
-1633.74% |
|
-1723.66% |
|
-1362.78% |
|
-1362.78% |
|
$-78.28M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
7.73 |
|
47.24 |
|
-24.11% |
|
-24.11% |
|
-22.72% |
|
-24.11% |
|
$11.33 |
|
$-2.35 |
|
$-2.35 |
|